Title : Activation of AKT/AP1/FoxM1 signaling confers sorafenib resistance to liver cancer cells.

Pub. Date : 2019 Aug

PMID : 31233189






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Activation of AKT/AP1/FoxM1 signaling confers sorafenib resistance to liver cancer cells. Sorafenib AKT serine/threonine kinase 1 Homo sapiens
2 Inhibition of AKT using BEZ-235 markedly suppressed the upregulation of c-jun and FoxM1, and increased the sensitivity of drug-resistant cells to sorafenib in vitro and in vivo. Sorafenib AKT serine/threonine kinase 1 Homo sapiens
3 The data indicated that the activation of the AKT/AP1/FoxM1 signaling axis is an important determinant of sorafenib tolerance. Sorafenib AKT serine/threonine kinase 1 Homo sapiens